Skip to Main content Skip to Navigation
Journal articles

COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors

Alessandro Leonetti 1, 2 Francesco Facchinetti 3, 4, * Teresa Zielli 1 Elena Brianti 4 Marcello Tiseo 1, 2
* Corresponding author
1 University Hospital of Parma [Parme, Italie]
2 University of Parma = Università degli studi di Parma [Parme, Italie]
3 PMNCO - Prédicteurs moléculaires et nouvelles cibles en oncologie
4 Fidenza Hospital [Parme, Italie]
Document type :
Journal articles
Complete list of metadata

Cited literature [8 references]  Display  Hide  Download
https://www.hal.inserm.fr/inserm-02565846
Contributor : Myriam Bodescot Connect in order to contact the contributor
Submitted on : Wednesday, May 6, 2020 - 4:54:59 PM
Last modification on : Thursday, September 2, 2021 - 10:14:47 AM

File

Vignette du document
PIIS0959804920301933.pdf
Publication funded by an institution

Identifiers

Collections

INSERM | FNCLCC | IGR | GS-HEALTH-DRUG-SCIENCES

Citation

Alessandro Leonetti, Francesco Facchinetti, Teresa Zielli, Elena Brianti, Marcello Tiseo. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors. European Journal of Cancer, Elsevier, 2020, 132, pp.122-124. ⟨10.1016/j.ejca.2020.04.004⟩. ⟨inserm-02565846⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

170

Files downloads

278